Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MF101

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
Review
2012
Review
2012
Introduction: The Women's Health Initiative Estrogen Plus Progestin clinical trial demonstrated the risks exceeded the benefits… Expand
2012
2012
Objective To evaluate the level of reduction in hot flushes among a cohort of postmenopausal women randomized to a phase-2… Expand
2011
2011
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Aromatase inhibitors (AI) have shown efficacy against… Expand
2010
2010
Estrogens are used extensively to treat hot flashes in menopausal women. Some of the beneficial effects of estrogens in hormone… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Highly Cited
2009
Highly Cited
2009
Estrogens produce biological effects by interacting with two estrogen receptors, ERα and ERβ. Drugs that selectively target ER… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
2009
2009
Objective: In randomized trials, the most common way to measure the effect of treatment on the frequency and severity of… Expand
Highly Cited
2008
Highly Cited
2008
After the Women's Health Initiative found that the risks of hormone therapy outweighed the benefits, a need for alternative drugs… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2008
2008
Liquiritigenin [2,3-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-(S)-4H-1-benzopyran-4-one] is one of the major active compounds of… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2007
Highly Cited
2007
Novel estrogenic therapies are needed that ameliorate menopausal symptoms and have the bone-sparing effects of endogenous… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5